Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Reggie Chambers Appointed to Vail Resorts Board of Directors
-
CueZen Selected to Participate in Microsoft for Startups Pegasus Program
-
Mobile Global Esports Announces Adjournment of Annual Meeting of Stockholders until March 25, 2024
-
Canterbury Park Holding Corporation Reports 2023 Fourth Quarter Results
-
LifeMD Reports Fourth Quarter 2023 Results
-
American Healthcare REIT Announces Dates For Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
-
AB Announces February 29, 2024 Assets Under Management
-
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
-
iRobot Provides First Quarter 2024 Financial Expectations and Reiterates 2024 Financial Outlook
-
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
-
ICF Awarded New $25 Million Contract by Entergy Arkansas
-
Vail Resorts Reports Fiscal 2024 Second Quarter Results, Increases Quarterly Dividend, and Provides Updated Fiscal 2024 Guidance
-
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2023 Results
-
Oracle Announces Fiscal 2024 Third Quarter Financial Results
-
ADAMS RESOURCES & ENERGY, INC. TO RELEASE FOURTH QUARTER AND FULL YEAR 2023 EARNINGS AND HOST CONFERENCE CALL ON MARCH 14
-
Mission Produce™ Announces Fiscal 2024 First Quarter Financial Results
-
Asana Announces Fourth Quarter and Fiscal Year 2024 Results
-
The Beachbody Company, Inc. Announces Q4 and FY 2023 Financial Results; Expects Positive Cash Flow from Operating Activities and Free Cash Flow in Q1 2024
-
The ONE Group Hospitality, Inc. to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast at 4:30 PM ET on March 14, 2024
-
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Ranpak Holdings Corp. Reports Fourth Quarter 2023 Financial Results
-
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024
-
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
-
Bowman Announces Fiscal Year 2023 Financial Results
-
GrowGeneration to Participate in the 36th Annual ROTH Conference
-
Grindr to Participate in the 36th Annual ROTH Conference
-
FCPT Declares First Quarter 2024 Dividend
-
RCM Technologies, Inc. Announces Conference Call
-
Sonendo Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Full Year 2024 Revenue Guidance
-
Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia
-
NET Power Reports Fourth Quarter and Year End 2023 Results and Provides Business Update
-
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
-
Verint to Announce Fourth Quarter and Full-Year Financial Results on Wednesday, March 27, 2024
-
Virtus Investment Partners Reports Preliminary February 29, 2024 Assets Under Management
-
Xerox Holdings Corporation Announces Closing of Convertible Notes Offering
-
Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
-
Spire Global Announces Participation in 36th Annual Roth Conference
-
HF Foods To Participate in the 36th Annual Roth Conference
-
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
-
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024
-
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
-
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Affirm to Webcast CFO Fireside Chat on March 22, 2024
-
FIGS Announces Participation in the 36th Annual Roth Conference
-
AMERISAFE Announces Date of Annual Meeting of Shareholders and Record Date
-
Modern Animal Expands in Los Angeles, Opens Tenth State-of-the-Art Veterinary Clinic to Elevate the Pet Care Experience
-
Crinetics Pharmaceuticals Announces March 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Copart Appoints Jeff Liaw as CEO and Director and Jay Adair as Executive Chairman
-
Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
-
Alto Ingredients, Inc. Enters Letter of Intent with Vault to Advance Carbon Capture and Storage Initiative


